Clinical Trial Update: Neoadjuvant Immunochemotherapy for Adenocarcinoma of the Esophagogastric Junction [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating neoadjuvant immunochemotherapy for adenocarcinoma at the esophagogastric junction; the study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Esophagogastric Junction
• Esophageal Cancer

Drugs mentioned

• Unspecified neoadjuvant immunochemotherapy regimen

Snippet

Sponsor: Shanghai Chest Hospital | Conditions: Esophageal Cancer | Phase 2 | Status: NOT_YET_RECRUITING